683 Capital Management’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
Other funds holding PYXS
683 Capital Management's PYXS Position: Q3 2026 in Review
683 Capital Management increased its Pyxis Oncology (PYXS) stake by 55% in Q3 2026, buying an estimated $770K and bringing the position to 714,000 shares worth $1.66M. The position accounts for 0.07% of the portfolio, ranked #112.
683 Capital Management first reported a position in PYXS in Q3 2024 and has held it in 9 quarters since. 101 funds tracked by Wall St. Rank hold PYXS as of Q3 2026.
- 683 Capital Management held 714,000 shares of Pyxis Oncology worth $1.66M as of Q3 2026.
- 683 Capital Management bought 254,633 Pyxis Oncology shares in Q3 2026, an estimated $770K.
- Pyxis Oncology made up 0.07% of 683 Capital Management's portfolio in Q3 2026, its #112 holding.
- 683 Capital Management first reported a position in Pyxis Oncology in Q3 2024 and has held it in 9 quarters since.
- 101 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2026.
Based on 683 Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.